Sustainability of Financing to Increase Drug Access and Distribution during National Health Insurance (JKN)

: Drug access for the public is largely influenced by four main factors, namely rational drug use, affordable prices, sustainable funding, and a health system and a reliable drug supply system. The study carried out qualitative and quantitative mixed methods with cross-sectional designs. Data collection is done through in-depth interviews and secondary data collection. The study was conducted in February-December 2017. The research sites in 11 provinces were selected purposively and divided into five regions were in accordance with the Indonesian Case-Based Groups (INA-CBGs) System. The results of the study show that the costs of purchasing drugs are sourced from the APBN and APBD, as well as capitation in several regions. For medicine, there is generally no problem with the cost of drug distribution. The problem of additional distribution costs occurs for the supply of medical devices. The anticipation of drug vacancies due to a shortage of APBN and DAK funds can be overcome by optimizing JKN capitation funds by imitating existing funding models. The supply of e-catalog drugs needed to be continuously evaluated by taking into account the certainty of the prices and availability of goods.